IASO Biotherapeutics Funding: $178M Raised, Series C (2021)
IASO Biotherapeutics is based in Pleasanton, California. It has raised $178M in total funding. Latest round: Series C.
IASO Biotherapeutics funding overview
IASO Biotherapeutics is based in Pleasanton, California. IASO Biotherapeutics has raised $178M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in September 2021. The round record for IASO Biotherapeutics runs through 2021; nothing later has been disclosed. Investors on record include CDH Baifu, CCB International, Everbright Limited, Co-Stone Capital, CNCB Capital, Plaisance Capital and 2 others. 8 distinct backers are named across the disclosed rounds.
Frequently asked about IASO Biotherapeutics funding
How much has IASO Biotherapeutics raised?
IASO Biotherapeutics has raised $178M in total disclosed funding across the rounds on record.
Who has invested in IASO Biotherapeutics?
CDH Baifu, CCB International, Everbright Limited, Co-Stone Capital, CNCB Capital, Plaisance Capital are named among the investors backing IASO Biotherapeutics.
What was the latest IASO Biotherapeutics funding round?
The most recent disclosed round is a Series C, announced in September 2021.
Where is IASO Biotherapeutics based?
IASO Biotherapeutics is based in Pleasanton, California.
When did IASO Biotherapeutics last raise?
The last disclosed IASO Biotherapeutics round closed in September 2021 at Series C.
IASO Biotherapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Pleasanton below to benchmark round size and investor mix.
